莫努匹韦多少钱一盒？

Up to now, although different types of novel coronavirus pneumonia (COVID-19) vaccines have been developed for clinical use, effective antiviral drugs are still lacking. In order to respond to the COVID-19 epidemic and enhance preparedness for future health emergencies, the development of oral antiviral drugs is necessary. In view of the results of the Phase III clinical trial, Monupivir was launched in the UK on November 4, 2021, becoming the world's first oral antiviral drug approved for the treatment of mild to moderate COVID-19 in adults (age ≥ 18 years old). So, how much does a box of Monupivir cost?

How much does Monupivir cost?

It is reported that the overseas price of Monupivir is higher than that of Paxlovid, with a course of treatment costing about US$700. As the world's first oral small molecule drug approved for COVID-19, Monupivir has currently obtained marketing authorization or emergency use authorization in more than 40 countries, but has not yet been approved in my country. Recently, its pharmaceutical company signed a cooperation framework agreement with a domestic company, granting it distribution rights and exclusive import rights in China.

It is currently reported that drugs outside the catalog in the new coronavirus diagnosis and treatment plan will be paid by medical insurance in advance until March 31, 2023, and the latest release of the "Novel Coronavirus Infection Diagnosis and Treatment Plan (Trial Tenth Edition)" also includes monopivir capsules. This also means that Monupivir capsules will receive temporary payment from medical insurance. But before that, the price of US$700 for a course of treatment had kept domestic patients away.

Prices of other versions of Monupivir

At present, more people choose to use the overseas version of Monupivir, which costs only 350$. If patients want to buy it, they can choose domestic and overseas medical service agencies to help them purchase it, which is relatively safe and convenient.

Recommended related articles: